Skip to content

Clinical trials

Phase 3 Arrhythmias, Cardiac trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arrhythmias, Cardiac Phase: Phase 3 Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20021
20041
20053
20062
20073
20082
20091
20112
20123
20134
20143
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated4
Unknown status2
Withdrawn2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)10
Biosense Webster, Inc.3
Forest Laboratories3
Janssen Scientific Affairs, LLC2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Sanofi2
AtriCure, Inc.1
Atrial Fibrillation Network1
Barts & The London NHS Trust1
Connolly, Stuart, M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arrhythmias, Cardiac47
Atrial Fibrillation25
Heart Diseases20
Cardiovascular Diseases14
Death, Sudden, Cardiac9
Ventricular Fibrillation7
Myocardial Infarction6
Stroke6
Tachycardia, Ventricular6
Heart Failure4

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.